$-0.04
(Market cap
--
Recently Viewed
Clear AllMarket cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
--
ROE
--
ROCE
--
Industry P/E
--
EV/EBITDA
--
Debt to Equity
--
Book Value
--
EPS
--
Face value
--
Shares outstanding
--
CFO
$-29.47 Mln
EBITDA
$-37.60 Mln
Net Profit
$-43.71 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Intelligent Bio Solutions Inc (INBS)
| -72.8 | -24.7 | -72.8 | -78.9 | -80.9 | -80.8 | -- |
|
BSE Sensex
| -9.5 | 5.5 | -6.0 | -4.3 | 8.7 | 9.9 | 11.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
Intelligent Bio Solutions Inc (INBS)
| -31.9 | -65.2 | -91.5 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates... intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York. Read more
President & CEO
Mr. Harry Simeonidis
President & CEO
Mr. Harry Simeonidis
Headquarters
New York, NY
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Intelligent Bio Solutions Inc (INBS) is $2.59 (NASDAQ) as of 24-Apr-2026 10:38 EDT. Intelligent Bio Solutions Inc (INBS) has given a return of -80.88% in the last 3 years.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-0.09
|
0.30
|
|
2024
|
-0.06
|
0.07
|
|
2023
|
-0.03
|
0.07
|
|
2022
|
-1.19
|
1.51
|
|
2021
|
-0.04
|
0.02
|
The 52-week high and low of Intelligent Bio Solutions Inc (INBS) are Rs 24.90 and Rs 2.42 as of 24-Apr-2026.
Intelligent Bio Solutions Inc (INBS) has a market capitalisation of $ 5 Mln as on 17-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Intelligent Bio Solutions Inc (INBS), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.